(Q38299065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

Vasanthanathan Poongavanam

8 March 2020

author

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Kislay Roy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Rikke Leth-Larsen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Michael Petersen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Jesper Wengel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3

Jagat R Kanwar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Maja Marušič

9

0 references

author name string

Stacey L Edwards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Kristine M Hillman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Neerati Prasad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Janez Plavec

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Rakesh N Veedu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

13 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

published in

Chemical Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

9499-9502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Locked nucleic acid as a novel class of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

BNAs: novel nucleic acid analogs with a bridged sugar moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

LNA: a versatile tool for therapeutics and genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Bevacizumab: a review of its use in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Aptamers as therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Enzymatic incorporation of LNA nucleotides into DNA strands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Efficient reverse transcription using locked nucleic acid nucleotides towards the evolution of nuclease resistant RNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Screening and improvement of an anti-VEGF DNA aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

Structural determinants of growth factor binding and specificity by VEGF receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CC02756J

21 January 2018

Identifiers

DOI

10.1039/C5CC02756J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25968110%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference